Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 2

2(40.0%)

Phase 3

1(20.0%)

5Total

N/A(2)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03275155Active Not Recruiting

Pathophysiology and Risk of Atrial Fibrillation Detected After Ischemic Stroke

Role: collaborator

NCT06843109Enrolling By Invitation

Biomarkers in a Candian Memory Clinic

Role: collaborator

NCT04789616Phase 2Recruiting

The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke

Role: collaborator

NCT03987126Phase 3Completed

Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction

Role: collaborator

NCT03448159Phase 2Completed

Fluoxetine Opens Window to Improve Motor Recovery After Stroke

Role: collaborator

NCT03338036Not ApplicableCompleted

The Effectiveness of Biofeedback for Individuals With Long-term Post-concussive Symptoms

Role: collaborator

NCT00141752Completed

Toronto Bedside Swallowing Screening Test (TOR-BSST) - A Bedside Swallowing Screening for Stroke Patients

Role: collaborator

NCT01572311Not ApplicableCompleted

Dual Task Aerobic Exercise for Older Adults With Cognitive Impairment (HM2)

Role: lead

All 8 trials loaded